Did YouTuber Nikocado Avocado use Ozempic for dramatic weight loss?

The Ukraine-born star, known for his mukbang videos, has lost an astonishing amount of weight after a 7 month hiatus.


Pop Culture & Art September 07, 2024
Photo: YouTube

YouTuber Nikocado Avocado has left fans stunned with his drastic 250-pound weight loss, sparking intense debate about whether he used the controversial weight loss drug Ozempic. The Ukraine-born star, known for his outrageous mukbang videos, has lost an astonishing amount of weight after a seven-month hiatus.

Nikocado Avocado, whose real name is Nicholas Perry, initially gained fame for his vegan mukbang videos, but soon shifted to consuming all kinds of food, leading to a significant weight gain. However, after a seven-month break, Perry returned with a shocking transformation, revealing a 250-pound weight loss in a 25-minute video titled Two Steps Ahead.

The YouTuber's dramatic weight loss has sparked intense debate, with some fans applauding his decision to prioritize his health, while others speculate that he may have used Ozempic to achieve such drastic results. Perry has yet to reveal his secret, but his transformation has undoubtedly captured the attention of many, sparking intense discussions online.

Fans have taken to social media to share their reactions, with some praising Perry's decision to prioritize his health, while others speculate about his weight loss methods. "Ozempic going OT! But I'm proud of him regardless," wrote one fan, while another commented, "Wow that's wild! But he did it."

As the debate continues to rage online, it's essential to remember that celebrities are human too, and their personal journeys should be approached with empathy and understanding. Nikocado Avocado's shocking weight loss may have sparked debate, but it's also a testament to the power of transformation and the importance of prioritizing one's health.
 

 

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ